Literature DB >> 31271831

Estradiol Acts in Lateral Thalamic Region to Attenuate Varicella Zoster Virus Associated Affective Pain.

Crystal Stinson1, Shaun M Logan1, Larry L Bellinger1, Mahesh Rao1, Paul R Kinchington2, Phillip R Kramer3.   

Abstract

Varicella zoster virus (VZV) results in chicken pox and herpes zoster. Female rats show a higher level of herpes zoster associated pain than males, consistent with human studies. In this study, we addressed the novel hypothesis that sex difference in herpes zoster associated pain is due, in part, to estradiol modulating activity in the thalamus. To test this hypothesis a high and low physiological dose of estradiol was administered to castrated and ovariectomized rats and the affective pain response was measured after injection of VZV into the whisker pad. Thalamic infusion of the estrogen receptor antagonist ICI 182,780 concomitant with a high dose of estradiol addressed the role of estradiol binding to its receptor to effect pain. Phosphorylated extracellular signal-regulated protein kinase (pERK) positive cells were measured in excitatory (glutaminase positive) and inhibitory (glutamate decarboxylase 67 positive) cells of the lateral thalamic region. Our results show that a high dose of estradiol significantly reduced the pain response in both males and females. pERK significantly increased in excitatory cells after treatment with a low dose of estradiol and increased in inhibitory cells after treatment with a high dose of estradiol. Administration of ICI 182,780 significantly increased the pain response, reduced expression of GABA related genes in the thalamic region and significantly reduced the number of inhibitory cells expressing pERK. The results suggest that estradiol attenuates herpes zoster pain by increasing the activity of inhibitory neurons within the thalamus and that this reduction includes an estrogen receptor dependent mechanism.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  estrogen; herpes zoster; orofacial; pain; shingles; thalamus

Mesh:

Substances:

Year:  2019        PMID: 31271831      PMCID: PMC6944200          DOI: 10.1016/j.neuroscience.2019.06.029

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  56 in total

1.  Response properties of TMJ units in superficial laminae at the spinomedullary junction of female rats vary over the estrous cycle.

Authors:  K Okamoto; H Hirata; S Takeshita; D A Bereiter
Journal:  J Neurophysiol       Date:  2003-03       Impact factor: 2.714

Review 2.  Sex and pain perception and analgesia.

Authors:  Cláudia Carneiro de Araújo Palmeira; Hazem Adel Ashmawi; Irimar de Paula Posso
Journal:  Rev Bras Anestesiol       Date:  2011 Nov-Dec       Impact factor: 0.964

3.  Reduced GABA(A) receptor α6 expression in the trigeminal ganglion alters inflammatory TMJ hypersensitivity.

Authors:  J Puri; P Vinothini; J Reuben; L L Bellinger; L Ailing; Y B Peng; P R Kramer
Journal:  Neuroscience       Date:  2012-04-19       Impact factor: 3.590

4.  Influence of 17beta-estradiol and progesterone on GABAergic gene expression in the arcuate nucleus, amygdala and hippocampus of the rhesus macaque.

Authors:  Nigel C Noriega; Dominique H Eghlidi; Vasilios T Garyfallou; Steven G Kohama; Sharon G Kryger; Henryk F Urbanski
Journal:  Brain Res       Date:  2009-10-13       Impact factor: 3.252

5.  Somatotopic maps within the zona incerta relay parallel GABAergic somatosensory pathways to the neocortex, superior colliculus, and brainstem.

Authors:  M A Nicolelis; J K Chapin; R C Lin
Journal:  Brain Res       Date:  1992-04-10       Impact factor: 3.252

6.  Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues.

Authors:  Georgina G J Hazell; Song T Yao; James A Roper; Eric R Prossnitz; Anne-Marie O'Carroll; Stephen J Lolait
Journal:  J Endocrinol       Date:  2009-05-06       Impact factor: 4.286

7.  Dual-phenotype GABA/glutamate neurons in adult preoptic area: sexual dimorphism and function.

Authors:  Erich N Ottem; Jonathan G Godwin; Sudha Krishnan; Sandra L Petersen
Journal:  J Neurosci       Date:  2004-09-15       Impact factor: 6.167

8.  The gad2 promoter is a transcriptional target of estrogen receptor (ER)alpha and ER beta: a unifying hypothesis to explain diverse effects of estradiol.

Authors:  Edward D Hudgens; Lan Ji; Clifford D Carpenter; Sandra L Petersen
Journal:  J Neurosci       Date:  2009-07-08       Impact factor: 6.167

9.  Diet and estrous cycle influence pain sensitivity in rats.

Authors:  C A Frye; C A Cuevas; R B Kanarek
Journal:  Pharmacol Biochem Behav       Date:  1993-05       Impact factor: 3.533

10.  Attenuation of myogenic orofacial nociception and mechanical hypersensitivity by viral mediated enkephalin overproduction in male and female rats.

Authors:  Phillip R Kramer; Mikhail Umorin; Larry L Bellinger
Journal:  BMC Neurol       Date:  2015-03-15       Impact factor: 2.474

View more
  4 in total

1.  Reduced activity of GAD67 expressing cells in the reticular thalamus enhance thalamic excitatory activity and varicella zoster virus associated pain.

Authors:  Rebecca Hornung; Addison Pritchard; Paul R Kinchington; Phillip R Kramer
Journal:  Neurosci Lett       Date:  2020-08-04       Impact factor: 3.046

2.  Role of sex hormones in modulating breast and ovarian cancer associated pain.

Authors:  Melissa C McHann; Henry L Blanton; Josée Guindon
Journal:  Mol Cell Endocrinol       Date:  2021-05-24       Impact factor: 4.369

3.  Comparing Gene Expression in the Parabrachial and Amygdala of Diestrus and Proestrus Female Rats after Orofacial Varicella Zoster Injection.

Authors:  Rebecca Hornung; Addison Pritchard; Paul R Kinchington; Phillip R Kramer
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

4.  17β-Estradiol Attenuates Neuropathic Pain Caused by Spared Nerve Injury by Upregulating CIC-3 in the Dorsal Root Ganglion of Ovariectomized Rats.

Authors:  Zhen-Zhen Xu; Qin-Yi Chen; Shi-Yu Deng; Meng Zhang; Chao-Yang Tan; Ke-Tao Ma; Li Li; Jun-Qiang Si; Li-Cang Zhu
Journal:  Front Neurosci       Date:  2019-11-08       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.